CareTrust REIT, Inc.

NYSE:CTRE Stock Report

Market Cap: US$8.8b

CareTrust REIT Future Growth

Future criteria checks 2/6

CareTrust REIT is forecast to grow earnings and revenue by 13% and 19.6% per annum respectively. EPS is expected to grow by 2.7% per annum. Return on equity is forecast to be 7.7% in 3 years.

Key information

13.0%

Earnings growth rate

2.68%

EPS growth rate

Health Care REITs earnings growth25.6%
Revenue growth rate19.6%
Future return on equity7.70%
Analyst coverage

Low

Last updated01 Jun 2026

Recent future growth updates

Recent updates

Narrative Update • Jun 01

CTRE: Forward Equity And Pipeline Deployment Will Drive Future Upside Potential

The updated analyst price target for CareTrust REIT edges up from about $43.67 to $44.91 per share, supported by recent Street revisions that lifted individual targets to $46 and $49 as analysts refreshed their models following Q1 healthcare REIT earnings and reaffirmed positive views on the stock. Analyst Commentary Recent Street commentary on CareTrust REIT has skewed constructive, with several bullish analysts lifting price targets after updating models around Q1 healthcare REIT earnings and reiterating positive stances on the stock.
Narrative Update • May 15

CTRE: Future Returns Will Reflect Accretive Pipeline And Execution On 2026 Plans

Analysts have nudged their average price target on CareTrust REIT to about $43.67, with recent research pointing to modestly higher expected profitability and updated assumptions for growth, capital deployment and valuation. Analyst Commentary Recent research on CareTrust REIT clusters around a similar message, with several firms adjusting price targets and updating models after the latest Q4 results and 2026 guidance.
Narrative Update • Apr 23

CTRE: Future Returns Will Reflect Accretive Pipeline And Aging Demographic Demand

The updated analyst price target for CareTrust REIT edges slightly lower to about $43.67 from $43.75, as analysts factor in modest adjustments to the discount rate and forward P/E, while maintaining generally supportive views on capital deployment and recent research upgrades. Analyst Commentary Bullish Takeaways Bullish analysts highlight CareTrust REIT's three operating platforms as a key driver for deploying capital accretively, which they see as supportive for the current valuation framework.
Narrative Update • Apr 09

CTRE: Future Returns Will Reflect Accretive Acquisitions Supported By Aging Demographic Demand

Analysts have slightly trimmed the CareTrust REIT fair value estimate to about $43.75, while still citing supportive views on capital deployment, acquisition-driven growth and aging demographic demand, as reflected in a series of recent price target increases across the Street. Analyst Commentary Recent Street research around CareTrust REIT has clustered around higher price targets and generally supportive commentary on the business model, with a few valuation and execution watchpoints that readers should keep in mind.
Narrative Update • Mar 26

CTRE: Future Returns Will Reflect Accretive Capital Deployment Across Three Platforms

Narrative Update Analysts have raised their average price target for CareTrust REIT to a range of $44 to $46, citing the company’s capacity to deploy capital across its platforms and expectations that recent FFO guidance adjustments and investment timing shifts can be absorbed over time. Analyst Commentary Recent research points to a generally constructive view on CareTrust REIT, with multiple firms lifting price targets and a mix of optimism on growth against some questions on guidance and expenses.
Seeking Alpha • Mar 13

CareTrust REIT: This Overlooked REIT's Hot Streak Continues, But The Bargain Is Gone (Rating Downgrade)

Summary CareTrust REIT is downgraded from buy to hold as its valuation appears stretched despite continued operational outperformance. CTRE delivered double-digit FFO and revenue growth robust acquisition activity and maintains a strong balance sheet with low leverage and high liquidity. Management guides for 9.4% FFO and FAD growth in 2026, with further upside possible if M&A accelerates in a lower-rate environment. While international expansion and diversification support the thesis, a current forward P/FFO of 21x and a 3.35% yield limit near-term upside. Read the full article on Seeking Alpha
Narrative Update • Mar 11

CTRE: Future Returns Will Reflect Accretive Platforms And Tight Senior Care Supply

The analyst price target for CareTrust REIT has edged up by about $0.27 as analysts factor in updated Q4 results, modestly lower discount rate assumptions, and ongoing opportunities to deploy capital across its operating platforms. Analyst Commentary Recent Street research on CareTrust REIT reflects a generally constructive tone, with several firms lifting their price targets following the latest Q4 update and refreshed 2026 guidance.
Narrative Update • Feb 25

CTRE: Future Returns Will Reflect Accretive 2026 Acquisitions And Tight Senior Care Supply

Analysts lifted the CareTrust REIT fair value estimate from $41.45 to $43.55 after a series of higher price targets in the $42 to $46 range. They pointed to updated FFO timing, acquisition opportunities across its operating platforms, and refreshed 2026 outlooks as key supports for the new target.
Narrative Update • Feb 09

CTRE: Future Returns Will Reflect Accretive Acquisitions And Tight Senior Care Supply

Narrative Update on CareTrust REIT The updated analyst price target for CareTrust REIT edges higher from US$41.36 to US$41.45, with analysts pointing to accretive acquisition activity, skilled nursing exposure, and supportive sector supply and demand as key drivers behind the refined fair value and P/E assumptions. Analyst Commentary Recent research updates on CareTrust REIT focus on its acquisition pipeline, exposure to skilled nursing facilities, and the supply backdrop in its core markets.
Narrative Update • Jan 25

CTRE: Future Returns Will Reflect Accretive Acquisitions And Skilled Nursing Demand

Analysts have lifted their CareTrust REIT fair value estimate from about US$40.70 to roughly US$41.36, citing more constructive views on future investment volumes, rent coverage, and acquisition driven growth. Analyst Commentary Bullish analysts have been revisiting their views on CareTrust REIT, with several recent research notes focusing on its acquisition pipeline, rent coverage, and exposure to senior care demand drivers.
Narrative Update • Jan 10

CTRE: Future Returns Will Balance Skilled Nursing Exposure And Accretive Acquisition Opportunities

Narrative Update The analyst price target for CareTrust REIT has moved modestly higher to about US$40.70. Analysts point to accretive acquisitions in a tight supply setting, aging demographics, and expectations for better investment volumes and rent coverage as key supports for their updated view.
Narrative Update • Dec 15

CTRE: Future Returns Will Reflect Skilled Nursing Strength And Rising Investment Volumes

Analysts have raised their price target on CareTrust REIT from $39.55 to $40.64 per share, citing expectations for stronger investment volumes, improving rent coverage, and slightly better long term growth and profitability assumptions. Analyst Commentary Recent research updates emphasize that bullish analysts see the revised price target as supported by both operational momentum and a robust external growth pipeline.
Narrative Update • Dec 01

CTRE: Future Performance Will Reflect Skilled Nursing Exposure And International Expansion

Analysts have raised their price target for CareTrust REIT from $38.44 to $39.55, citing anticipated positive estimate revisions due to stronger investment volumes and robust rent coverage in skilled nursing facilities. Analyst Commentary Recent analyst coverage has focused on CareTrust REIT's outlook and valuation following its adjusted price target.
Narrative Update • Nov 17

CTRE: Future Expansion and Leadership Transition Will Shape International Outlook

Analysts have slightly raised their price target for CareTrust REIT from $37.89 to $38.44. This reflects updated forecasts that balance a modestly lower expected revenue growth and profit margin with a reduced discount rate and increased projected future valuation.
Narrative Update • Nov 03

CTRE: Capital Raise And UK Acquisition Will Drive Balanced Future Performance

Analysts have raised their price target for CareTrust REIT to $36, up from previous estimates by as much as $4. They cite strong capital deployment and the company's significant investment pipeline following its recent share issuance.
Narrative Update • Oct 20

UK Care Home Entry And Diversification Will Secure Enduring Potential

CareTrust REIT’s analyst price target has increased modestly from $37.56 to $37.89. Analysts cite the company’s enlarged equity raise and active investment pipeline as supportive factors for improved valuations.
Narrative Update • Oct 05

UK Care Home Entry And Diversification Will Secure Enduring Potential

Analysts have increased their price target for CareTrust REIT to $37.56 from $36.89. They cite a robust investment pipeline, improved profit margins, and strong capital deployment as key supporting factors for the positive outlook.
Narrative Update • Sep 04

UK Care Home Entry And Diversification Will Secure Enduring Potential

The consensus analyst price target for CareTrust REIT was maintained at $36.89, as analysts cite the successful equity offering and strengthened balance sheet as supporting a robust investment pipeline and near-term growth. Analyst Commentary Upsized follow-on equity offering generating $736M in gross proceeds, providing significant funding.
Narrative Update • Aug 20

UK Care Home Entry And Diversification Will Secure Enduring Potential

CareTrust REIT’s consensus price target was raised to $35.33 as analysts anticipate enhanced growth and financial flexibility following a successful capital raise, robust investment pipeline, and strengthened balance sheet. Analyst Commentary Successful completion of a 20M share upsized issuance, providing gross proceeds up to $736M, which increases liquidity and funds investment opportunities.
Seeking Alpha • Mar 17

CareTrust REIT: Buy This Ship Before It Sails (Rating Upgrade)

Summary CareTrust REIT, Inc. has shown strong financial performance with robust FFO growth and significant acquisitions, enhancing its investment appeal. CTRE's robust balance sheet, with ultra-low net debt-to-EBITDA of 0.5x and ample liquidity, supports its aggressive acquisition strategy and dividend growth. Favorable policy expectations and high-quality operators position CTRE well for continued expansion, justifying an upgrade from Hold to Buy. Read the full article on Seeking Alpha
Seeking Alpha • Feb 25

CareTrust REIT: Expected Double-Digit Growth And Recent Pullback Make This Stock A Long-Term Buy

Summary CareTrust REIT's strong balance sheet and double-digit FFO growth in a challenging economy make it a compelling buy for long-term investors. The REIT's impressive acquisition spree and robust pipeline position it for continued growth, despite macroeconomic uncertainties and high interest rates. With no debt maturing for the next 3 years and a well-covered dividend yield over 4%, CTRE offers significant upside potential. Current valuation remains attractive, and management's guidance for 2025 suggests further double-digit growth, making CTRE an ideal long-term investment. Read the full article on Seeking Alpha
Seeking Alpha • Jan 16

CareTrust REIT: A Growth And Cashflow Engine Serving A Vital Society Need

Summary In my initial coverage of CareTrust REIT, I'm calling it a buy, agreeing with the bullish sentiment from analysts and the quant system. Macro factors point to continued demand growth for senior living and skilled nursing facilities. This REIT keeps growing its property portfolio, though much of it so far has been concentrated in Texas and California. CTRE stock's profit margin beats similar peers, and it has a proven positive cashflow, increasing the likelihood the dividend will be supported. This REIT has the lowest debt/equity among the peer group selected, and stable/positive credit ratings from major agencies. Read the full article on Seeking Alpha
Seeking Alpha • Dec 18

CareTrust REIT: An Acquisition Titan That's Still A Buy For Long-Term Investors

Summary CareTrust REIT remains a buy due to strong fundamentals, impressive acquisitions, and a recent price pullback, offering long-term growth potential. The REIT's acquisition spree, totaling nearly $1 billion in 2023, has significantly boosted FFO and revenue, showcasing robust growth despite economic challenges. CareTrust's fortress balance sheet, low leverage, and potential credit rating upgrade position it for further upside and acquisition opportunities. Risks include high tenant exposure to The Ensign Group and significant property concentration in California, but the overall outlook remains positive for long-term investors. Read the full article on Seeking Alpha
Seeking Alpha • Dec 04

CareTrust REIT: Strong Fundamentals And Growth Potential - Buy

Summary I rate CareTrust REIT a buy due to its strong fundamentals, consistent financial performance, and promising growth prospects driven by acquisitions and demographic trends. CTRE's financials are impressive, with consistent revenue growth, stable operating expenses, and a strong balance sheet, justifying its premium valuation. The company's robust market position, diversified portfolio, and extensive geographical presence provide stability and growth opportunities, particularly in high-demand states like California and Texas. Despite trading at a premium, CTRE's growth potential, solid financial footing, and strategic acquisitions make it a compelling investment opportunity in the healthcare REIT sector. Read the full article on Seeking Alpha
Seeking Alpha • Sep 24

CareTrust REIT: Looking For Healthcare Exposure? You Should Consider This REIT

Summary CareTrust REIT is a top choice for healthcare exposure as well as REIT exposure, with strong growth potential and an impressive 1H performance. CTRE's robust balance sheet and strategic acquisitions have driven significant share price appreciation, outperforming peers and the broader market. Despite economic risks, CareTrust REIT's strong fundamentals and healthcare sector stability justify a continued buy rating, with an upside price target of $35.49. Despite economic risks, CTRE's solid fundamentals and favorable macro environment support a continued "buy" rating as I see further upside in the next 12 months. CTRE's high exposure to top tenant, The Ensign Group, could negatively impact the REIT should the economy see a slowdown. Read the full article on Seeking Alpha
Seeking Alpha • Sep 10

CareTrust REIT Surges: Riding High On Skilled Nursing Strength

Summary CareTrust REIT has shown strong fundamentals with high rent collection, a 9.9% yield on new investments, and a robust balance sheet with low leverage. The company is well-positioned for growth, benefiting from favorable Medicare rate increases and acquisition opportunities in the skilled nursing sector. Despite these strengths, CTRE's current P/FFO of 20.2 suggests a 'Hold' rating, making it less attractive for value investors at its current price. A more reasonable entry point would be around $25, aligning with a P/FFO of 17x, offering a better margin of safety. Read the full article on Seeking Alpha
User avatar
New Narrative • Sep 02

Aggressive Expansion And Critical Acquisitions Set To Propel Revenue Growth Amid Market Optimism

Aggressive expansion and strategic focus on quality operators promise sustained long-term revenue growth through higher occupancy rates and rent escalations.

Earnings and Revenue Growth Forecasts

NYSE:CTRE - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2028911471N/AN/A2
12/31/2027778427N/AN/A3
12/31/2026647363N/AN/A3
3/31/2026523335397413N/A
12/31/2025476321379394N/A
9/30/2025428261334348N/A
6/30/2025373219301315N/A
3/31/2025330162257267N/A
12/31/2024296125236244N/A
9/30/202426999206212N/A
6/30/202424874184190N/A
3/31/202423063159168N/A
12/31/202321854144155N/A
9/30/202321041135146N/A
6/30/202320433133143N/A
3/31/202320055138145N/A
12/31/2022196-8137144N/A
9/30/2022194-4144149N/A
6/30/20221927151155N/A
3/31/20221938156158N/A
12/31/202119271151157N/A
9/30/202118774162156N/A
6/30/202118484155148N/A
3/31/202118082146143N/A
12/31/202017881146146N/A
9/30/202017880130140N/A
6/30/202016649123132N/A
3/31/202016849126133N/A
12/31/201916346N/A126N/A
9/30/201916041N/A122N/A
6/30/201916665N/A119N/A
3/31/201915859N/A107N/A
12/31/201815758N/A99N/A
9/30/201815344N/A94N/A
6/30/201814741N/A86N/A
3/31/201814030N/A91N/A
12/31/201713326N/A89N/A
9/30/201712532N/A82N/A
6/30/201711928N/A81N/A
3/31/201711234N/A70N/A
12/31/201610529N/A64N/A
9/30/20169926N/A61N/A
6/30/20169019N/A53N/A
3/31/20168213N/A44N/A
12/31/20157510N/A40N/A
9/30/2015685N/A34N/A
6/30/2015667N/A30N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CTRE's forecast earnings growth (13% per year) is above the savings rate (3.5%).

Earnings vs Market: CTRE's earnings (13% per year) are forecast to grow slower than the US market (16.2% per year).

High Growth Earnings: CTRE's earnings are forecast to grow, but not significantly.

Revenue vs Market: CTRE's revenue (19.6% per year) is forecast to grow faster than the US market (11.2% per year).

High Growth Revenue: CTRE's revenue (19.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CTRE's Return on Equity is forecast to be low in 3 years time (7.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/05 18:37
End of Day Share Price 2026/06/05 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CareTrust REIT, Inc. is covered by 25 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David RodgersBaird
Amanda SweitzerBaird
Steven ValiquetteBarclays